3-(2-methylprop-2-en-1-yl)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea
Structure Info
- Chemspace ID
- CSSB02522304849 (In-Stock Building Blocks)
- IUPAC Name
- 3-(2-methylprop-2-en-1-yl)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea
- Mol formula
- C17H25BN2O3
- Mol weight
- 316 Da
- Catalog Number(s)
- BBLS02522304849, BBV-325628941, EN300-54737382, bbls02522304849
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.1
- Heavy atoms count
- 23
- Rotatable bond count
- 4
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.47
- Polar surface area (Å)
- 60
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 2
![Chemical structure of 3-(2-methylprop-2-en-1-yl)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea (C17H25BN2O3) - CSSB02522304849](/st/structure/200/f209c427ab487131715dfe8265202110/CC%2528%253DC%2529CNC%2528%253DO%2529NC1%253DCC%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png "C17H25BN2O3")
- Zoom the structure
- CSSB02522304849
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of 1-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2-methylprop-2-en-1-yl)urea - CSSB03570838458](/st/structure/200/582b1ce685f5253e51eaf7fd9d7641f6/CC%2528%253DC%2529CNC%2528%253DO%2529Nc1cc%2528ccc1C%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2.png)
![Chemical structure of 1-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2-methylprop-2-en-1-yl)urea - CSSB03575178539](/st/structure/200/863f2b08a1d9d7baa3b9e72420f983b5/CC%2528%253DC%2529CNC%2528%253DO%2529Nc1cccc%2528B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529c1C.png)
![Chemical structure of 1-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2-methylprop-2-en-1-yl)urea - CSSB03570838455](/st/structure/200/43e719ae2985e4777dbeb7ac90b6518e/CC%2528%253DC%2529CNC%2528%253DO%2529Nc1ccc%2528C%2529c%2528c1%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2.png)
![Chemical structure of 1-[2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2-methylprop-2-en-1-yl)urea - CSSB03570929762](/st/structure/200/612b2e699a97319e3f870e6908305433/CC%2528%253DC%2529CNC%2528%253DO%2529Nc1cccc%2528B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529c1F.png)
![Chemical structure of 1-[2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2-methylprop-2-en-1-yl)urea - CSSB03576936066](/st/structure/200/bd6ee6a4e9edd9b1ce8214e1e52f09f5/CC%2528%253DC%2529CNC%2528%253DO%2529Nc1cc%2528ccc1F%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2.png)
![Chemical structure of 1-[2-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2-methylprop-2-en-1-yl)urea - CSSB06745685937](/st/structure/200/6d9fc2d63f76eb1c4eff69f1bd590b24/CC%2528%253DC%2529CNC%2528%253DO%2529Nc1cccc%2528B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529c1Cl.png)
![Chemical structure of 1-[3-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2-methylprop-2-en-1-yl)urea - CSSB15013097678](/st/structure/200/80d1ced8ecaa04e7e6f753734e414a3b/CC%2528%253DC%2529CNC%2528%253DO%2529NC1%253DCC%2528Cl%2529%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
